Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVAIL-KT
NCT07430683Phase 4Active, not recruiting
- Sponsor
- Universidad de Guadalajara
- Start
- Mar 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by Universidad de Guadalajara. Started Mar 2024; status: active, not recruiting.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT07430683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07430683.